EASL has published several reports on liver disease in Europe and is commissioning work on future publications.
EASL welcomes the initiative of the European Commission to propose actions to increase the uptake of vaccination against the Hepatitis B virus and human papillomaviruses. In its response, EASL calls on the EU Member States to prioritise key actions, especially to upscale HBV vaccination rates, by encouraging Member States to implement stronger national strategies and…
Read More
The European Association for the Study of the Liver (EASL) welcomes the European Commission’s initiative to build an EU Cancer Inequalities Registry and recommends the inclusion of inequalities in liver cancer and in its key causes: liver cirrhosis due to viral hepatitis, alcohol-related liver disease (ARLD), or non-alcoholic fatty liver disease (NAFLD). Around 90% of…
Read More
EASL endorsed a Joint Statement, together with other 15 organisations. EASL welcomes the European framework for action on alcohol 2022–2025 and endorses the evidence-based language of the Framework and supports the six areas for priority action.
Read More
International organisations representing doctors, cancer patients, young people, researchers, public health and development advocates across Europe issued the Oslo Declaration- a call for policy action to curb alcohol harm. Europe is the heaviest alcohol consuming region in the world. The burden of alcohol related harms to individuals, families, communities and society is enormous. Half of…
Read More
Geneva, 27 May 2022: In Europe, the number of deaths from liver cancer has doubled in the past 30 years. Screening for liver cancer with an ultrasound examination every six months is an established method to reduce mortality resulting from liver cancer. EASL guidelines recommend that screening for liver cancer is offered to patients with…
Read More
EASL submitted a written statement at the 72nd Session of the WHO Regional Committee for Europe taking place 12- 14 September 2022 in Tel Aviv, Israel. EASL strongly supports the efforts for the prevention and control of Noncommunicable Diseases in the WHO European Region 2016-2025 and asked WHO Europe to incorporate the NAFLD into their…
Read More
Geneva, 3 May 2022: This joint statement of the European Centre for Disease Prevention and Control (ECDC), World Health Organization (WHO) and EASL provides an overview of public health guidance aimed to ensure that the needs of refugees in relation to viral hepatitis are appropriately met, for all stages along the continuum of care from…
Read More
Brussels, 4 March 2022. On this World Obesity Day, social, health and consumer organisations call on the EU to adopt strong regulation to protect children from the marketing of nutritionally poor food. Obesity is on the rise among European citizens, negatively impacting both people’s quality of life and life expectancy and increasing the incidence of…
Read More
EASL and other health organisations wrote a joint press release with regards to the Parliamentary Report “Strengthening Europe in the fight against cancer” (BECA report). The health community is appalled that Members of European Parliament have listened to the alcohol industry rather than to scientists and public health experts.
Read More
EASL recommends extending the Recommendation to liver cancer for high-risk groups living with chronic liver diseases; these patients are identifiable, have a high risk of liver cancer, and can be offered curative treatment if their liver cancer is diagnosed early. Furthermore, liver cancer detection tools are easily available and affordable.
Read More